DK424383A - Fremgangsmaade til fremstilling af doseringsenheder af cis-platin(ii)diamindichlorid - Google Patents

Fremgangsmaade til fremstilling af doseringsenheder af cis-platin(ii)diamindichlorid Download PDF

Info

Publication number
DK424383A
DK424383A DK424383A DK424383A DK424383A DK 424383 A DK424383 A DK 424383A DK 424383 A DK424383 A DK 424383A DK 424383 A DK424383 A DK 424383A DK 424383 A DK424383 A DK 424383A
Authority
DK
Denmark
Prior art keywords
diamindichloride
platin
cis
procedure
dosage units
Prior art date
Application number
DK424383A
Other languages
English (en)
Other versions
DK157168C (da
DK424383D0 (da
DK157168B (da
Inventor
Gaetano Batteli
Diego Oldani
Alessandro Rigamonti
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK424383D0 publication Critical patent/DK424383D0/da
Publication of DK424383A publication Critical patent/DK424383A/da
Publication of DK157168B publication Critical patent/DK157168B/da
Application granted granted Critical
Publication of DK157168C publication Critical patent/DK157168C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK424383A 1982-09-23 1983-09-16 Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid DK157168C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
IT2339682 1982-09-23

Publications (4)

Publication Number Publication Date
DK424383D0 DK424383D0 (da) 1983-09-16
DK424383A true DK424383A (da) 1984-03-24
DK157168B DK157168B (da) 1989-11-20
DK157168C DK157168C (da) 1990-04-09

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
DK424383A DK157168C (da) 1982-09-23 1983-09-16 Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid

Country Status (20)

Country Link
US (1) US4670262A (da)
JP (1) JPS5978117A (da)
AT (1) AT382077B (da)
AU (1) AU559499B2 (da)
BE (1) BE897761A (da)
CA (1) CA1211372A (da)
CH (1) CH655852A5 (da)
DE (1) DE3333024A1 (da)
DK (1) DK157168C (da)
FI (1) FI78236C (da)
FR (1) FR2533439B1 (da)
GB (1) GB2127291B (da)
GR (1) GR79055B (da)
IE (1) IE56173B1 (da)
IL (1) IL69752A (da)
IT (1) IT1153974B (da)
NL (1) NL8303211A (da)
SE (1) SE464061B (da)
SU (1) SU1424722A3 (da)
ZA (1) ZA836904B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A7 (fi) * 1988-11-14 1990-05-15 Bristol Myers Squibb Co Hypertoninen cisplatin-liuos
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
ATE173627T1 (de) * 1992-09-04 1998-12-15 Fuji Chem Ind Co Ltd Medizinische zusammensetzung
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
CZ302498B6 (cs) * 1999-11-15 2011-06-15 Pharma Mar, S. A. Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
IL155273A0 (en) * 2000-10-12 2003-11-23 Pharma Mar Sa Pharmaceutical compositions comprising an aplidine compound
ES2571219T3 (es) 2001-01-25 2024-09-23 The United States Of America Represented By The Sec Dep Of Health And Human Services Formulación de compuestos de ácido borónico
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
WO2003026642A1 (en) * 2001-09-21 2003-04-03 Sumitomo Pharmaceuticals Co., Ltd. Freeze-dried pharmaceutical preparation
DE60229414D1 (de) * 2001-10-19 2008-11-27 Pharma Mar Sa Verwendung von aplidine in der behandlung von pankreaskrebs
EP1620117A4 (en) * 2003-03-12 2009-07-29 Pharma Mar Sa IMPROVED ANTITUMORAL TREATMENTS
AU2004218883B2 (en) * 2003-03-12 2009-10-01 Dana-Farber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
WO2007101235A2 (en) * 2006-02-28 2007-09-07 Pharma Mar, S.A. Improved antitumoral treatments
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CA2717409A1 (en) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Improved anticancer treatments
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
CA2735899A1 (en) * 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
AU541056B2 (en) * 1980-03-31 1984-12-13 Bristol-Myers Company Pharmaceuticals formulations

Also Published As

Publication number Publication date
SE8304920D0 (sv) 1983-09-13
GB8324380D0 (en) 1983-10-12
AU1908983A (en) 1984-03-29
IE832172L (en) 1984-03-23
AT382077B (de) 1987-01-12
IT8223396A0 (it) 1982-09-23
CA1211372A (en) 1986-09-16
IL69752A (en) 1986-07-31
FI833300A7 (fi) 1984-03-24
FI78236B (fi) 1989-03-31
GR79055B (da) 1984-10-02
FI833300A0 (fi) 1983-09-15
FI78236C (fi) 1989-07-10
IT1153974B (it) 1987-01-21
IE56173B1 (en) 1991-05-08
SE8304920L (sv) 1984-03-24
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
ZA836904B (en) 1984-10-31
DK157168C (da) 1990-04-09
FR2533439B1 (fr) 1986-08-14
GB2127291A (en) 1984-04-11
DK424383D0 (da) 1983-09-16
ATA326283A (de) 1986-06-15
IL69752A0 (en) 1983-12-30
FR2533439A1 (fr) 1984-03-30
BE897761A (fr) 1984-01-02
GB2127291B (en) 1986-01-15
AU559499B2 (en) 1987-03-12
JPS5978117A (ja) 1984-05-04
NL8303211A (nl) 1984-04-16
DE3333024A1 (de) 1984-03-29
SE464061B (sv) 1991-03-04
DK157168B (da) 1989-11-20
CH655852A5 (de) 1986-05-30

Similar Documents

Publication Publication Date Title
DK424383A (da) Fremgangsmaade til fremstilling af doseringsenheder af cis-platin(ii)diamindichlorid
DK438983D0 (da) Fremgangsmade til fremstilling af n-substituerede benzimidazoler
DK1183A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK473183A (da) Fremgangsmaade til fremstilling af orale dosisformer
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK299483D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK211783A (da) Fremgangsmaade til fremstilling af pyrazolpyridinforbindelser
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK283083A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
NO833664L (no) Fremgangsmaate til fremstilling av 4-metyl-5-alkyl-tiometylimidazoler
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK519183A (da) Fremgangsmaade til fremstilling af oxazolinoazetidinon-forbindelser
DK62283A (da) Fremgangsmaade til fremstilling af peptidergotalkaloider
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
DK9383A (da) Fremgangsmaade til fremstilling af phosphinoxider
DK10883D0 (da) Fremgangsmade til fremstilling af substituerede chloracetanilider
DK193983D0 (da) Fremgangsmade til fremstilling af substituerede phenylendiaminer
DK66483D0 (da) Fremgangsmade til fremstilling af ergotalkaloider

Legal Events

Date Code Title Description
PBP Patent lapsed